Skip to content

DBV Technologies DBVT Return on assets

Return on assets at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-71.1%-127pp
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-45%+18.8pp
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-45.4%-1,198pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-31%-6.8pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-24.3%-2.2pp
Alumis Inc. logo
Alumis Inc.ALMS
-50.9%

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$948.17M+269%
Enterprise value$725.07M+188%
P/S163.9×+91.4×

Profitability

See full
Operating margin-2,910.4%-265pp
Net margin-2,895.4%-257pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Calculated from DBV Technologies’s reported figures.

Based on trailing twelve months.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's return on assets?
DBV Technologies (DBVT) reported return on assets of -105.7% in Q1 2026.
How has DBV Technologies's return on assets changed year-over-year?
DBV Technologies's return on assets increased by 8.7% year-over-year, from -115.7% to -105.7%.
What is the long-term trend for DBV Technologies's return on assets?
Over 5 years (2020 to 2025), DBV Technologies's return on assets has grown at a 10.9% compound annual growth rate (CAGR), from -58.7% to -98.2%.
What does return on assets mean?
Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.